Kolexia
Marret Gregoire Oncologie médicale
Marret Gregoire
Oncologie médicale
Clcc Institut Curie
Paris, France
75 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Tumeurs du foie Tumeurs de la prostate Récidive tumorale locale Cholangiocarcinome Tumeurs du col de l'utérus

Collaborateurs

Voir plus
Le Tourneau Christophe
Le Tourneau Christophe
Clcc Institut Curie, Paris, France
Borcoman Edith
Borcoman Edith
Clcc Institut Curie, Paris, France
Bieche Ivan
Bieche Ivan
Institut Curie, Saint-Cloud, France
Oudard Stephane
Oudard Stephane
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
B3TSI
7 collaboration(s)
Dernière en 2021
Ipsos (France)
2 collaboration(s)
Dernière en 2020
EXAFIELD
1 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Is Primary Poorly Differentiated Sarcomatoid Malignancy of the Parotid Gland Sarcomatoid Undifferentiated/Dedifferentiated Melanoma ? Report of three unusual cases diagnosed by fine needle aspiration combined with histological, immunohistochemical and molecular analyses.
Acta cytologica   04 mars 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC biology   20 février 2024
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Scientific reports   18 décembre 2023
923P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma – subgroup analysis of the PEVOsq basket trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
864P Serial cell-free tumor DNA in prognosing survival in patients with head and neck squamous cell carcinoma treated with upfront surgery
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
872P Prognostic value of pathological intratumor heterogeneity in patients with head and neck squamous cell carcinoma treated with upfront surgery
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers: A Phase Ib/II Trial Evaluating the Combination of TG4001 and Avelumab in Patients With HPV-16 Positive Recurrent or Metastatic Malignancies.
Essai Clinique (Transgene)   01 août 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
European journal of cancer (Oxford, England : 1990)   11 juillet 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Nature communications   22 juin 2023
Abstract 3363: Spatial and longitudinal tumor heterogeneity in head and neck squamous cell carcinoma patients treated with primary surgery
Proceedings: AACR Annual Meeting 2023   01 avril 2023